Ligand Pharmaceuticals, Inc. (LGND) Tops Q1 EPS by 7c; Approves $5M Buyback

May 8, 2013 4:14 PM

Ligand Pharmaceuticals, Inc. (NASDAQ: LGND) reported Q1 EPS of $0.16, $0.07 better than the analyst estimate of $0.09. Revenue for ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found